Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Lintzeris

Showing results (111-120 of 196) with videos related to

Pageof 20
Sort By:
Drug and Alcohol Review|April 30, 2013
An examination of the influences on New South Wales general practitioners regarding the provision of opioid substitution therapySimon Holliday, Parker Magin, Christopher Oldmeadow, et al.
Pain Medicine (Malden, Mass.)|October 4, 2014
Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilizationSuzanne Nielsen, Nicholas Lintzeris, Raimondo Bruno, et al.
Pharmacoeconomics|September 4, 2017
Systematic Review of the Costs and Benefits of Prescribed Cannabis-Based Medicines for the Management of Chronic Illness: Lessons from Multiple SclerosisSamuel Herzog, Marian Shanahan, Peter Grimison, et al.
The International Journal on Drug Policy|July 26, 2016
Alprazolam use and related harm among opioid substitution treatment clients - 12 months follow up after regulatory reschedulingRachel M Deacon, Suzanne Nielsen, Stefanie Leung, et al.
Drug and Alcohol Dependence Reports|April 25, 2025
Characterizing withdrawal from long-acting injectable buprenorphine: An observational case seriesVictoria Hayes, Llewellyn Mills, Gaye Byron, et al.
Drug and Alcohol Review|May 6, 2025
Clinicians' Perspectives on Cannabis Use and Cannabis Treatment in Clients Undertaking Opioid Dependence TreatmentLaila Parvaresh, Llewellyn Mills, Jaleh Gholami, et al.
Journal of Substance Abuse Treatment|August 20, 2015
The characteristics of a cohort who tamper with prescribed and diverted opioid medicationsBriony Larance, Nicholas Lintzeris, Raimondo Bruno, et al.
Harm Reduction Journal|May 28, 2024
Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22)Llewellyn Mills, Jonathon C Arnold, Anastasia Suraev, et al.
Drug and Alcohol Review|November 12, 2013
Validation and implementation of the Australian Treatment Outcomes Profile in specialist drug and alcohol settingsAnni Ryan, Jennifer Holmes, Vi Hunt, et al.
Pain Medicine (Malden, Mass.)|May 27, 2015
Pharmaceutical Opioid Use and Dependence among People Living with Chronic Pain: Associations Observed within the Pain and Opioids in Treatment (POINT) CohortGabrielle Campbell, Suzanne Nielsen, Briony Larance, et al.
Pageof 20

Showing results (111-120 of 196) with videos related to

Sort By:
Pageof 20
Drug and Alcohol Review|April 30, 2013
An examination of the influences on New South Wales general practitioners regarding the provision of opioid substitution therapySimon Holliday, Parker Magin, Christopher Oldmeadow, et al.
Pain Medicine (Malden, Mass.)|October 4, 2014
Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilizationSuzanne Nielsen, Nicholas Lintzeris, Raimondo Bruno, et al.
Pharmacoeconomics|September 4, 2017
Systematic Review of the Costs and Benefits of Prescribed Cannabis-Based Medicines for the Management of Chronic Illness: Lessons from Multiple SclerosisSamuel Herzog, Marian Shanahan, Peter Grimison, et al.
The International Journal on Drug Policy|July 26, 2016
Alprazolam use and related harm among opioid substitution treatment clients - 12 months follow up after regulatory reschedulingRachel M Deacon, Suzanne Nielsen, Stefanie Leung, et al.
Drug and Alcohol Dependence Reports|April 25, 2025
Characterizing withdrawal from long-acting injectable buprenorphine: An observational case seriesVictoria Hayes, Llewellyn Mills, Gaye Byron, et al.
Drug and Alcohol Review|May 6, 2025
Clinicians' Perspectives on Cannabis Use and Cannabis Treatment in Clients Undertaking Opioid Dependence TreatmentLaila Parvaresh, Llewellyn Mills, Jaleh Gholami, et al.
Journal of Substance Abuse Treatment|August 20, 2015
The characteristics of a cohort who tamper with prescribed and diverted opioid medicationsBriony Larance, Nicholas Lintzeris, Raimondo Bruno, et al.
Harm Reduction Journal|May 28, 2024
Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22)Llewellyn Mills, Jonathon C Arnold, Anastasia Suraev, et al.
Drug and Alcohol Review|November 12, 2013
Validation and implementation of the Australian Treatment Outcomes Profile in specialist drug and alcohol settingsAnni Ryan, Jennifer Holmes, Vi Hunt, et al.
Pain Medicine (Malden, Mass.)|May 27, 2015
Pharmaceutical Opioid Use and Dependence among People Living with Chronic Pain: Associations Observed within the Pain and Opioids in Treatment (POINT) CohortGabrielle Campbell, Suzanne Nielsen, Briony Larance, et al.
Pageof 20